Claritev Drops Amid Reports of Expanded DOJ Antitrust Probe
Claritev (CTEV) fell 8.5% after reports surfaced that the U.S. Justice Department is expanding its antitrust investigation into claims the company aided insurers in coordinating to lower out-of-network reimbursement rates for healthcare providers.
Tickers: $CTEV
Topics: antitrust data analytics healthcare insurance